Skip to content

Efficacy of hypertonic saline irrigation for nasal symptoms in children with perennial allergic rhinitis: A randomized double-blind study

Efficacy of hypertonic saline irrigation for nasal symptoms in children with perennial allergic rhinitis : A randomized double-blind study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210125004
Enrollment
60
Registered
2021-01-25
Start date
2021-01-27
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergic rhinitis (AR) is one of the most common chronic diseases affecting 15-25% of worldwide children. In Thailand, an estimated AR prevalence is between 10 and 45%. AR is an inflammatory disorder of nasal mucosa marked by nasal congestion, rhinorrhea, and itching, often accompanied by sneezing and conjunctival inflammation. AR is recognized as a major chronic respiratory disease of children because of its high prevalence, detrimental effects on quality of life and school performance, and com

Interventions

to use 5 ml with disposable syringes to irrigate each nostril twice a day for a period of 4 weeks,to use 5 ml with disposable syringes to irrigate each nostril twice a day for a period of 4 weeks
Experimental Drug,Active Comparator Drug
3% hypertonic saline nasal irrigation,Normal saline nasal irrigation

Sponsors

Bhumibol Adulyadej Hospital, Royal Thai Air Force
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 15 Years

Inclusion criteria

Inclusion criteria: 1. age 6 to 15 years, 2. allergist diagnosed AR status with positive skin prick test, 3. total nasal symptom score greater than equal 4 at the first visit of this study

Exclusion criteria

Exclusion criteria: 1. nasal anatomic defects, 2. abnormal nasal ciliary function, 3. chronic respiratory tract infection, 4. ongoing allergen-specific immunotherapy 5. moderate-severe persistent asthma.

Design outcomes

Primary

MeasureTime frame
Nasal symptom 4 weeks Total nasal symptom score

Secondary

MeasureTime frame
Quality of life 4 weeks Quality of life question

Countries

Thailand

Contacts

Public ContactKittithat Rattanamaneewong

Bhumibol Adulyadej Hospital, Royal Thai Air Force

sukittithat@hotmail.com66840196050

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026